Early patient data suggests that FlowOx™ may be able to alleviate Multiple Sclerosis (MS) symptoms
A case series report on 7 patients conducted by Gabriela Fortes (MD), Neurologist, suggests that FlowOx™ has a surprising and profound effect in alleviating MS related spasticity and pain.
An exploratory clinical trial is currently being carried out by Neuro-SysMed, Norway’s leading center of excellence in Neurological research, to confirm the case series findings.
IN THE PRESS
First RCT to show improved walking capacity
First multi-centre randomized controlled trial using FlowOx™, published in Journal of Vascular Surgery, shows improved walking capacity for patients with intermittent claudication, also known as “windows shopper’s disease”.
Read more here!
OUR PARTNERS
ABOUT FLOWOX™
Is FlowOx™ for me?
What is FlowOx™?
A revolutionary new technology for the treatment of reduced peripheral micro circulation
How does it work?
FlowOx™ works by exercising the blood vessels from the small arteries to the capillaries in the outer layers of the skin.
Who can benefit from using FlowOx™?
FlowOx™ is recommended for patients of over 18 years who suffer from blood flow deficiencies in the lower limbs such as:
a) Peripheral arterial disease (PAD),
b) Diabetic and non-diabetic arteriopathic foot and leg ulcers,
c) Intermittent claudication and rest pain,
d) Foot and lower leg ulcers of mixed aetiology associated with immobility such as paraplegia following spinal injury.
Can FlowOx™ be integrated into an existing therapy?
FlowOx™ is an additional treatment and can be used in conjunction with standard care (typical wound care and medication).
Without FlowOx™ I would have lost my other leg as well and I am not sure I would have been here today. That is what FlowOx™ has done for me..
Listen to Stine’s and Hans Thomas’ stories
Stine’s own story
First FlowOx™ patient, Hans Thomas
OTIVIO
FlowOx™ by Otivio
Otivio AS is a Norwegian medtech company based in Oslo. FlowOx™ is a non-invasive medical device for home treatment addressing insufficient blood flow to the limbs associated with peripheral arterial disease, diabetes and other arterial blood flow deficiencies. FlowOx™ is documented to reduce or eliminate these outcomes which represent a big impact on Quality of Life and health care costs. FlowOx™ is CE marked (CE2460) and available in various countries.
GET IN TOUCH